-
Mashup Score: 0Acknowledging Racism, Building Trust — Conversations That Matter in Maternal Medicine | NEJM - 9 hour(s) ago
Recognizing their increased risks during pregnancy and frustrated by the slow pace of change, an Ob/Gyn decides to discuss racism and risks with Black and Indigenous patients at their first visit.
Source: www.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy | NEJM - 10 hour(s) ago
Two patients had autoimmune hemolytic anemia that relapsed after CD19 CAR T-cell therapy but responded rapidly to BCMA-targeted T-cell–engager therapy with remission, minimal side effects, and …
Source: www.nejm.orgCategories: General Medicine NewsTweet-
Two patients had autoimmune hemolytic anemia that relapsed after CD19 CAR T-cell therapy but responded rapidly to BCMA-targeted T-cell–engager therapy with remission, minimal side effects, and hematologic improvement. Learn more: https://t.co/Jhni7W8897 https://t.co/GzSZVWOjih
-
-
Mashup Score: 14
First-line treatment with encorafenib plus cetuximab (EC) with or without chemotherapy (oxaliplatin, leucovorin, and fluorouracil [mFOLFOX6]) for BRAF V600E–mutated metastatic colorectal cancer, an…
Source: www.nejm.orgCategories: General Medicine NewsTweet-
Presented at #ASCO25: The addition of encorafenib and cetuximab to mFOLFOX6 chemotherapy improved outcomes in the primary treatment of metastatic BRAF V600E–mutated colorectal cancer. Full BREAKWATER phase 3 trial results: https://t.co/NNkryRQjCa https://t.co/3auuDaCS25
-
-
Mashup Score: 22Malnutrition in Older Adults | NEJM - 11 hour(s) ago
Malnutrition in older adults is common, underrecognized, and contributes to poor health and risk of death. Guidelines are available to facilitate prevention and treatment of malnutrition.
Source: www.nejm.orgCategories: General Medicine NewsTweet-
Malnutrition in Older Adults. https://t.co/9EFtrhCbOB @NEJM @JWatch @NEJMEvidence @NEJMGroup #Geriatrics #GeriOnc #PallOnc https://t.co/FVzTn2y2TO
-
-
Mashup Score: 141
An interim analysis of progression-free survival in this trial showed that ibrutinib–venetoclax was superior to fludarabine–cyclophosphamide–rituximab (FCR) among patients with chronic lymphocytic …
Source: www.nejm.orgCategories: General Medicine NewsTweet-
➡️➡️Big CLL news! Munir et al OS and PFS adv for MRD driven I&V over ibrutinib in 1L #CLL #EHA2025 Congrats to all FLAIR trial 🇬🇧group Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia | New England Journal of Medicine https://t.co/7Odds8kWZK
-
-
Mashup Score: 41Nerandomilast in Patients with Progressive Pulmonary Fibrosis | NEJM - 17 hour(s) ago
Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory properties. Nerandomilast has been shown to slow the progr…
Source: www.nejm.orgCategories: General Medicine NewsTweet-
Original Article: Nerandomilast in Patients with Progressive Pulmonary Fibrosis (FIBRONEER-ILD phase 3 trial) https://t.co/WLtx356sBv #ATS2025 | @atscommunity https://t.co/Irf3AXfoam
-
-
Mashup Score: 8
In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and dec…
Source: www.nejm.orgCategories: General Medicine News, Expert PicksTweet-
Published in @NEJM 📎 https://t.co/IV8cOGbCiO #ACC25 #LBCT @ACCinTouch https://t.co/TgBU3MAR4V
-
-
Mashup Score: 20Cyclophosphamide Therapy in Childhood Neuroblastoma | NEJM - 1 day(s) ago
THE role of chemotherapy in the management of the child with neuroblastoma remains to be defined. Until recently, conventional therapy has consisted of a combination of surgery and radiotherapy, wh…
Source: www.nejm.orgCategories: General Medicine NewsTweet-
From the NEJM Archive: Cyclophosphamide Therapy in Childhood Neuroblastoma (Original Article, June 18, 1964) https://t.co/X6nSkOLxKM https://t.co/ogCvQmLkcg
-
-
Mashup Score: 53
Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality …
Source: www.nejm.orgCategories: General Medicine News, General Journals & SocietTweet-
Presented at #ASGCT2025: A lipid nanoparticle–delivered base-editing therapy was custom designed for an infant with a ureacycle disorder. The affected infant was treated at approximately 7 and 8 months of age. Read the Brief Report: https://t.co/EtnnBhGfqi Editorial: https://t.co/56A43OZuy2
-
-
Mashup Score: 23Cardiac Injury Detected by Smartwatch | NEJM - 2 day(s) ago
A 76-year-old retired cardiovascular nurse presented to the ED with 2 hours of chest pain triggered by severe emotional distress and associated with changes in the electrocardiogram on her smartwatch.
Source: www.nejm.orgCategories: General Medicine NewsTweet-
Weekend Briefing for June 7, 2025: New Images in Clinical Medicine: Cardiac Injury Detected by Smartwatch https://t.co/S9QKOnZ7xF Two New Perspectives: 1️⃣ Addressing Antifungal Drug Resistance https://t.co/XR7HfnF0nh 2️⃣ Acknowledging Racism, Building Trust https://t.co/1yAF6F3vM2
-
Recognizing their increased risks during pregnancy and frustrated by the slow pace of change, an Ob/Gyn decides to discuss racism and risks with Black and Indigenous patients at their first visit. Read the Perspective essay by Bronwen F. Kahn, MD: https://t.co/ODYYwIuHH2 https://t.co/xT1776ktyF